SAM
GILD icon

Sunnymeath Asset Management’s Gilead Sciences GILD Stock Holding History

Sunnymeath Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$61K Hold
850
– – 0.09% 94
2016
Q3 		$65K Hold
850
– – 0.14% 85
2016
Q2 		$71K Hold
850
– – 0.1% 87
2016
Q1 		$78K Buy
+850
New +$76.7K 0.12% 85

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sunnymeath Asset Management's GILD Position: Q4 2016 in Review

Sunnymeath Asset Management held its Gilead Sciences (GILD) position steady in Q4 2016 at 850 shares worth $61K. The position accounts for 0.09% of the portfolio, ranked #94.

Sunnymeath Asset Management first reported a position in GILD in Q1 2016 and has held it in 4 quarters since. The position peaked at $78K in Q1 2016. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Sunnymeath Asset Management held 850 shares of Gilead Sciences worth $61K as of Q4 2016.
  • Sunnymeath Asset Management left its Gilead Sciences share count unchanged in Q4 2016.
  • Gilead Sciences made up 0.09% of Sunnymeath Asset Management's portfolio in Q4 2016, its #94 holding.
  • Sunnymeath Asset Management first reported a position in Gilead Sciences in Q1 2016 and has held it in 4 quarters since.
  • Sunnymeath Asset Management's Gilead Sciences position peaked at $78K in Q1 2016.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Sunnymeath Asset Management's 13F filing for Q4 2016, filed 13 Jan 2017.